Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

33%

6 trials in Phase 3/4

Results Transparency

8%

1 of 12 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
10(62.5%)
Phase 3
5(31.3%)
Phase 4
1(6.3%)
16Total
N/A(10)
Phase 3(5)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT04362085Phase 3Completed

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care

Role: collaborator

NCT02834416Phase 3Completed

ADT Exercise Trial and Economic Analysis

Role: collaborator

NCT03810820Not ApplicableUnknown

Remote ECG Monitoring of TAVI Patients

Role: collaborator

NCT04369690Unknown

The Psychological, Social, and Economic Impacts of COVID-19

Role: collaborator

NCT03448562Not ApplicableUnknown

CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF

Role: collaborator

NCT04232709Not ApplicableTerminated

Evaluating the CAREchart@Home™ Program for Enhancing After-hours Cancer Care

Role: collaborator

NCT04004858Not ApplicableUnknown

Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT)

Role: lead

NCT03942614Not ApplicableCompleted

Nordic Pole Walking for Individuals With Cancer

Role: collaborator

NCT03910192Not ApplicableUnknown

Mindfulness to Reduce Ambulatory Hypertension in Atrial Fibrillation

Role: collaborator

NCT00729911Phase 4Completed

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

Role: collaborator

NCT03583983Not ApplicableCompleted

The DNA-Based Lifestyle Enhancement Trial

Role: collaborator

NCT02206880Completed

The Delirium-CS Canada Study

Role: collaborator

NCT01851525Not ApplicableCompleted

Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Role: lead

NCT01648621Not ApplicableCompleted

Program of Integrated Care for Patients With Chronic Obstructive Pulmonary Disease and Multiple Comorbidities

Role: collaborator

NCT01006876Phase 3Completed

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

Role: collaborator

NCT01045668Phase 3Completed

Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT Ablation

Role: collaborator

NCT01173809Phase 3Completed

Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation

Role: collaborator

NCT00848796Not ApplicableCompleted

Comparative Study of Two Brands of Heparin Already on the Market

Role: lead

All 18 trials loaded